SLC5A2 and type 2 diabetes mellitus: The safety and efficacy of SGLT2 inhibitors during prolonged fasting periods, as observed in our study, suggest that these medications could be a viable option for individuals with Type 2 diabetes who engage in fasting for weight management or metabolic health.